Company Filing History:
Years Active: 2017-2018
Title: Innovations by Wei-Chang Wang
Introduction
Wei-Chang Wang is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the treatment of metabolic disorders. With a total of 6 patents to his name, his work focuses on innovative methods to improve health outcomes.
Latest Patents
Wei-Chang Wang's latest patents include groundbreaking methods for addressing fatty liver disease and insulin resistance. One of his inventions describes a method to reduce blood aspartate transaminase levels, liver weight, hepatic lipid accumulation, and hepatocyte hypertrophy by administering a probiotic bacterium to subjects showing signs of fatty liver disease. This probiotic bacterium can therefore be used to treat fatty liver disease. Another significant patent provides a method to reduce insulin resistance and improve glucose tolerance through the administration of the same probiotic bacterium, which can be utilized to treat insulin resistance, metabolic syndrome, and type 2 diabetes.
Career Highlights
Wei-Chang Wang is currently associated with Chang Gung Biotechnology Corporation, where he continues to develop innovative solutions in biotechnology. His work has garnered attention for its potential impact on public health.
Collaborations
Some of his notable coworkers include Yun-Fei Ko and Jan Martel, who contribute to the collaborative efforts in research and development within the company.
Conclusion
Wei-Chang Wang's contributions to biotechnology through his patents reflect his commitment to improving health outcomes. His innovative approaches to treating metabolic disorders highlight the importance of research in developing effective therapies.